Recently, Qingyunshan Traditional Chinese Medicine has been awarded the project support of Nanling Team Program for its research on the integration of green biosynthesis of natural health products based on big data with new generation of intelligent information technology and its industrialization demonstration.
What is Nanling Team Program
Nanling Team Program is centered on key areas and emerging industries, especially industry segments that can quickly seize the industrial high ground, fill the industrial gaps, and generate significant economic benefits, focusing on relying on domestic and foreign scientific research activity, good R & D conditions, strong scientific and technological innovation strength of universities, scientific research institutes, enterprises and institutions, as well as domestic and foreign well-known scientific research teams, with projects, technologies, funds to Shaosha to start business or set up and cultivate scientific research platforms to carry out strategic, forward-looking, and innovative research. Cultivate scientific research platform, carry out strategic, forward-looking, key common technology research, technological innovation and achievement transformation, enhance the industry's technical level, and advanced technology at home and abroad, with better market prospects and industrialization potential results in Shaoshaos realize industrialization.
Guangdong Qingyunshan Chinese Medicine Innovation Research and Development Co., Ltd. is a subsidiary of Qingyunshan Pharmaceuticals, the project undertaken, employing well-known experts in the industry at home and abroad, the formation of the Russian Academy of Engineering foreign academician led by a team of 16 high-level talent, including foreign academicians 1, 2 national talents, 3 people with high titles, 4 people with doctoral degrees. This is an important step in the implementation of the company's talent strategy, aimed at high-level talent specialization through innovation, so that the "seeds" of health industrialization to take root.
Layout of diversified talent strategy
Stimulate the kinetic energy of high-quality development
Talent is the key to development, the basis of competition and the source of vitality. Along the way, Qingyunshan Pharmaceutical has spared no effort in talent development strategy. Up to now, the headquarters and subsidiaries of Taiyi Health together have a total of more than 100 research and development personnel, production technicians, accounting for more than 20% of the total number of employees. We always put great emphasis on diversified talents. According to the company's business strategy, we build natural raw material development center, functional finished product development center, product evaluation center, product transformation center, etc., which can provide multi-faceted career platforms for all types of talents; we construct talent chain with industry chain, and enhance industry chain with talent chain, so as to realize the "dual chain" interaction and efficient operation. "At the same time, we also continue to improve the talent protection system to provide a good environment for the development of talents in all aspects.
In the future, Qingyunshan will continue to focus on high-level scientific and technological innovation talents, and continuously improve the competitiveness of the enterprise in talent, science and technology and industry, and open up new horizons by virtue of the talent advantage.
